CNMD - CONMED Corporation
79.14 0.00 (0.00%)
After hours: 4:39PM EDT
| Previous Close | 79.42 |
| Open | 79.41 |
| Bid | 77.06 x 800 |
| Ask | 80.48 x 800 |
| Day's Range | 78.33 - 80.75 |
| 52 Week Range | 56.91 - 84.38 |
| Volume | 237,404 |
| Avg. Volume | 330,845 |
| Market Cap | 2.234B |
| Beta (3Y Monthly) | 0.78 |
| PE Ratio (TTM) | 56.13 |
| EPS (TTM) | 1.41 |
| Earnings Date | Apr 24, 2019 |
| Forward Dividend & Yield | 0.80 (0.96%) |
| Ex-Dividend Date | 2019-03-14 |
| 1y Target Est | 85.75 |
- Zacks•5 days ago
Conmed (CNMD) Reports Next Week: What You Should Expect
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•8 days ago
What Makes Conmed (CNMD) a New Buy Stock
Conmed (CNMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
- Business Wire•11 days ago
CONMED Corporation Announces Amended Start Time for Annual Meeting of Shareholders
CONMED Corporation (CNMD) today announced an amended start time for its Annual Meeting of Shareholders. As previously announced, the meeting will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 22, 2019. CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures.
- Zacks•18 days ago
XRAY vs. CNMD: Which Stock Is the Better Value Option?
XRAY vs. CNMD: Which Stock Is the Better Value Option?
- Simply Wall St.•18 days ago
Is CONMED Corporation's (NASDAQ:CNMD) CEO Paid Enough Relative To Peers?
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! In 2014 Curt Hartman was appointed CEO of CONMED Corporation (NASDAQ:CNMD). First, this article will compare CEO c...
- Business Wire•20 days ago
CONMED Corporation to Announce First Quarter 2019 Financial Results on April 24, 2019
CONMED Corporation (CNMD) today announced that it will report financial results for the first quarter of 2019 after the market close on Wednesday, April 24, 2019. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 844-889-7792 (domestic) or 661-378-9936 (international) and refer to the passcode 9275258.
- Markit•20 days ago
See what the IHS Markit Score report has to say about Conmed Corp.
Conmed Corp NASDAQ/NGS:CNMDView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low and declining Bearish sentimentShort interest | PositiveShort interest is low for CNMD with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on March 18. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $766 million over the last one-month into ETFs that hold CNMD are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•last month
XRAY vs. CNMD: Which Stock Should Value Investors Buy Now?
XRAY vs. CNMD: Which Stock Is the Better Value Option?
- Zacks•last month
BioScrip (BIOS) Reports Loss in Q4, Both Margins Contract
The combined expertise of BioScrip (BIOS) and OptionCare is expected to drive significant growth for the former.
- Zacks•last month
Nevro (NVRO) Q4 Loss Wider Than Expected, Revenues Beat
Nevro's (NVRO) solid domestic and international performance aids Q4 results.
- Business Wire•last month
CONMED Corporation Announces Annual Meeting of Shareholders
CONMED Corporation today announced that its Annual Meeting of Shareholders will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 22, 2019, at 3:30 p.m.
- Zacks•last month
Avanos (AVNS) Q4 Earnings Beat, Revenues Miss, Shares Down
Avanos (AVNS) registers solid growth in the Chronic Care and Pain Management segments in Q4.
- Zacks•2 months ago
AMN Healthcare (AMN) Q4 Earnings Top, Revenues Lag Estimates
AMN Healthcare's (AMN) Q4 results get a boost from Nurse and Allied Solutions and Other Workforce Solutions segments.
- Zacks•2 months ago
Cooper Companies' (COO) Q1 Earnings Beat, Revenues Rise Y/Y
Strong performance by Cooper Companies' (COO) CSI and CVI segments drove the top line in first-quarter fiscal 2019.
- Zacks•2 months ago
GNC Holdings' (GNC) Q4 Earnings Miss Estimates, Margins Fall
GNC Holdings' (GNC) international segment registers revenue growth in the fourth quarter.
- Zacks•2 months ago
HMS Holdings' (HMSY) Q4 Earnings Beat, Revenues Rise Y/Y
Strong performance in Analytical Services drove HMS Holdings' (HMSY) performance in Q4.
- Zacks•2 months ago
PRA Health's (PRAH) Q4 Earnings Top, Revenues Lag Estimates
PRA Health (PRAH) gains from solid segmental contributions in Q4.
- Zacks•2 months ago
Inogen (INGN) Q4 Earnings Beat Estimates, Rental Revenues Up
Inogen (INGN) gains from solid direct-to-consumer revenues in Q4; strong business-to-business revenues in the United States.
- Zacks•2 months ago
OPKO Health (OPK) Reports Loss in Q4, Misses on Revenues
OPKO Health (OPK) witnesses sluggishness in the Products revenues segment in Q4. However, contribution from RAYALDEE has been significant in the quarter.
- Zacks•2 months ago
Penumbra (PEN) Earnings and Revenues Beat Estimates in Q4
Penumbra (PEN) sees strength across all segments in Q4.
- Zacks•2 months ago
Patterson Companies (PDCO) Earnings Match Estimates in Q3
Patterson Companies (PDCO) gains from solid segmental contributions in Q3.
- Zacks•2 months ago
Amedisys (AMED) Tops Earnings and Revenue Estimates in Q4
At the Home Health and Hospice divisions, Amedisys (AMED) gains from growth in Medicare and non-Medicare revenues in Q4.
- Zacks•2 months ago
Orthofix (OFIX) Earnings Beat Estimates in Q4, Margins Fall
Orthofix (OFIX) revenues across majority product lines witness year-over-year growth.
- Zacks•2 months ago
Tandem (TNDM) Posts Earnings in Q4, Revenues Top Estimates
The roll-out of t:slim X2 with Basal-IQ technology, increased supply capacity and renewal sales, as well as the international launch, drive Tandem's (TNDM) Q4 revenues.
